Search for: "IN RE: PHARMACY BENEFIT MANAGERS ANTITRUST LITIGATION" Results 1 - 16 of 16
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Sep 2022, 4:33 pm by Cynthia Marcotte Stamer
As companies that purchased health insurance and their employees or other individuals who received health insurance from certain Blue Cross Blue Shield entities wait to hear how to claim their share of the $2.67 billion In re: Blue Cross Blue Shield Antitrust Litigation private federal class action civil antitrust lawsuit settlement (“Settlement”) finally approved August 9, 2022 against the Blue Cross Blue Shield Association… [read post]
5 Jul 2022, 10:32 am by Dan Lopez
From 1989 to 1995, she consulted in private practice in litigation support for regulatory and antitrust matters. [read post]
19 May 2023, 2:19 pm by Daniel J. Gilman
” The most likely route to this, according to the FTC complaint, would be to exploit bargaining leverage with pharmacy benefit managers (PBMs) to secure favorable placement in the formularies that PBMs design for various health plans. [read post]
15 Sep 2023, 10:26 am by Daniel J. Gilman
The core of the consent agreement has Amgen agreeing to do what they’d offered to do all along; that is, agree not to enter into contracts with pharmacy benefit managers (PBMs) or health plans for drug-formulary designs that would preclude entry by competitor products to the drugs at issue (Tepezza and Krystexxa), should such products successfully complete Phase III clinical trials, gain marketing approval from the U.S. [read post]
20 Jan 2018, 8:43 am by Zuri Blackmon
In re UnitedHealth Group PBM Litigation, 16-3352, D. [read post]
25 Sep 2009, 1:37 pm by Lisa Baird
In a precedential decision issued Thursday, In Re: Pharmacy Benefit Managers Antitrust Litigation (MDL 1782), the U.S. [read post]
9 Mar 2020, 1:21 pm by Unknown
Different on medical benefit (physician-administered) side from pharmacy benefit side. [read post]
6 Oct 2009, 10:00 pm
In re Pharmacy Benefit Managers Antitrust Litigation, No. 07-1151, slip op., 2009 WL 3030370 (3d Cir. [read post]
9 Aug 2016, 10:44 am by Chris Castle
But I don’t have a personal agenda here, other than trying to ensure that consumers get the benefits of competition and do not see higher prices or less innovation as a result of conduct that harms competition. [read post]
26 Nov 2012, 7:28 am by Gary Mason
”   In re: Pharmacy Benefit Managers Antitrust Litigation, MDL  1782, No, 12-1430 (3rd Cir,  Sept. 10. 2012). [read post]
16 Apr 2015, 5:26 am
 [Defendant’s] healthcare systems department worked with managed care organizations, TPPs, and pharmacy benefit managers to maximize reimbursement or coverage for products like Actiq.Id. at *5 (emphasis added). [read post]
15 Mar 2017, 11:48 am by Jeffrey Neuburger
Blockchain is being implemented to facilitate electronic medical records, patent data management, hospital and pharmacy administration, insurance and claims processing and related patient care systems. [read post]
5 Sep 2008, 11:01 pm
: (Excess Copyright), (Michael Geist), Opinion and analysis of C-61: (Michael Geist), (Michael Geist), (Michael Geist), (Michael Geist), (Michael Geist), (Michael Geist), 61 reforms to C-61: (Day 50: Education harms – lessons contain limited definition of students – Michael Geist), (Day 51: Education internet exception is unnecessary – Michael Geist), (Day 52: Education internet exception is harmful – Michael Geist), (Day 53: Education internet exception… [read post]